 AnPac Bio-Medical Science Co., Ltd. AnPac Bio, the Company or we ANPC, a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today that Frost Sullivan has recently ranked AnPac Bio number three globally and number one in China in liquid biopsy for both clinical and commercial samples in the year of 2019 in cancer screening. AnPac Bios proprietary CDA platform utilizes combination tests which can both screen for overall cancer risk as well as provide cancer location information. 